In trading on Tuesday, shares of Denali Therapeutics Inc (Symbol: DNLI) crossed above their 200 day moving average of $23.11, changing hands as high as $23.33 per share. Denali Therapeutics Inc ...
Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained 26.6% against the industry’s decline of 14.3%. The stock has also ...
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) was the recipient of a significant growth in short interest in the month of December.As of December 31st, there was short interest ...
Analyst Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) and keeping the price target at ...
The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s Rich Ross is prepared for that rally to continue, shrugging off fears ...
The new Trump administration offers an opportunity to rework regulation in the US to make it more attractive for companies to tap public markets, Nasdaq Inc. Chief Executive Officer Adena Friedman ...
Apple Stock Performance Shares of NASDAQ:AAPL opened at $229.98 on Monday. The company has a debt-to-equity ratio of 1.51, a current ratio of 0.87 and a quick ratio of 0.83. The business’s 50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback